15 Mar
2016
Irritable Bowel Syndrome With Diarrhea Drugs Market Valued At $289.3 Mn In 2015, And Expected To $1,115.06 Mn By 2022 Expanding At A CAGR Of 13.89% From 2016-2022
27 Feb
2018
Opioid Induced Constipation (OIC) Drugs Market Was Valued At US$ 2,430.6 Mn In 2017, And Is Expected To Reach US$ 3,770.4 Mn By 2026 Expanding At A CAGR Of 4.92% From 2018 To 2026 : Increasing Demand From Pharmaceuticals Industry Is Driving The Market growth by credenceresearch.com.
15 Mar
2016
Chronic idiopathic constipation (CIC) drugs market was valued at USD 1675.4 Mn in 2015, and is expected to reach USD 2570.8 Mn by 2022, expanding at a CAGR of 6.4% from 2016 to 2022.
08 Mar
2018
Laxatives Market Was Valued At US$ 5,274.6 Mn In 2017, And Is Expected To Reach US$ 8,734.2 Mn By 2026, Expanding At A CAGR Of 5.8% From 2018 To 2026 Increasing Demand From Pharmaceuticals Industry Is Driving The Market Growth By credenceresearch.com. Going Well And Which Are Not? And Leading Players
08 Mar
2018
CNS biomarkers projected to gain maximum demand during the forecast period from 2018 to 2026 primarily due to extensive ongoing development in personalised medicines and application of biomarkers in diagnosis.
20 Mar
2016
Irritable bowel syndrome (IBS) is defined as persistent abdominal discomfort and pain occurring with changed bowel habits. This condition is classified into three types centered upon the prevalent bowel habits; IBS with diarrhea (IBS-D), IBS with constipation (IBS-C) and IBS with mixed presentations (IBS-M). It is among the most common gastrointestinal disorders with a worldwide prevalence of approximately 11%. As of 2014, more than 30 million individuals older than age 19 suffered from IBS across key national markets namely the U.S., U.K. France, Italy, Germany, Japan and Spain.
14 Jun
2019
The mycosis fungoides market is set to project sublime growth at a compounded annual growth rate (CAGR) of 4.9% during the forecast period from 2019 to 2027.
14 Apr
2016
Angina Pectoris Treatment Market Valued At $7,962.8 Mn In 2015 And Is Expected To Reach $12,589.6 Mn By 2022 Expanding At CAGR Of 5.2% From 2016-2022
02 May
2016
In-Vitro Diagnostics Market Was Valued At USD 60,468.7 Mn In 2015, And Is Expected To Reach USD 81,345.1 Mn By 2022, Expanding At A CAGR Of 4.2% From 2016 To 2022
13 Jul
2022
In 2021, the global Alzheimer’s Therapeutic market was valued at USD 2491.5 million and is projected to reach the value of USD 4201.54 million by 2028.
05 May
2016
This report on global osteoarthritis treatment market studies various type of therapeutics used for treatment of osteoarthritis along with pipeline analysis of upcoming potential drugs. Globally, osteoarthritis is the eighth leading cause of disability with the joint most frequently associated with disability being the knee. The current treatment available for osteoarthritis treatment is incapable due to lack of efficacy and serious side-effects associated with the long term use.
17 May
2016
This report on global Listeria monocytogenes infections treatment market studies various drugs used for treatment of Listeria monocytogenes infection’s along with pipeline analysis of upcoming potential drugs. According to Centers for Disease Control and Prevention (CDC), Listeriosis, a serious infection usually caused by eating food contaminated with the bacterium Listeria monocytogenes, is an important public health problem in the United States.
07 Sep
2022
The Barotrauma Market is anticipated to grow at a substantial CAGR of 6.40% in the upcoming years. The Global Barotrauma industry was estimated to be worth USD xx billion in 2021 and was expected to be worth USD xx billion by 2028.
18 May
2016
This report on ADME toxicology testing market studies various product and technology types. ADME is the abbreviation for absorption, distribution, metabolism and elimination, a pharmacology and pharmacokinetics term that describes the disposition of a drug or compound inside the human body. ADME comprises set of four processes that develop the performance of a drug on human tissue and ADME toxicology testing is applied for the development of a new drug.
19 May
2016
This report on global autoimmune diseases treatment market studies various drugs used for treatment of autoimmune diseases along with pipeline analysis of upcoming potential drugs. Autoimmune diseases (ADs) are a family of more than 80 chronic, and often disabling, illnesses broadly characterized by immune system dysfunction leading to the loss of tolerance to self-antigens, presence of increased level of autoantibodies, inflammatory and mediatory cells and resulting chronic inflammation.
26 May
2016
Intravenous solutions present a combination of nutrients that support patients to get essential nutrition. The demand for intravenous solutions on the global front is undergoing steady growth and its market presents a higher growth in Asia-Pacific region. Intravenous products are highly regulated for quality and availability assurance.
31 May
2016
Global Von Willebrand Disease (VWD) Treatment Market was estimated to be USD XX Bn in 2016 and was expected to be worth USD XX Bn by 2022. Explore the market Here!
01 Jun
2016
Global Cytomegalovirus (CMV) Infection Treatment Market was estimated to be USD XX Bn in 2016 and was expected to be worth USD XX Bn by 2022. Explore the market Here!
19 Jan
2017
Global Acquired Hemophilia Treatment Market was estimated to be USD XX Bn in 2016 and was expected to be worth USD XX Bn by 2023. Explore the market Here!
09 Jun
2016
Breast cancer is the most common form of cancer found in women across the globe. Although the rate of incidence of breast cancer has decreased in the past few years, reducing the mortality rate even further remains a big concern. Tamoxifen reduces the effects of the estrogen hormone in human body. The drug is used to treat/prevent breast cancer for both women and men. Tamoxifen can also be used to cure other kinds of cancers.
09 Jun
2016
This report on global glioblastoma multiforme market studies various drugs used for treatment of glioblastoma along with pipeline analysis of upcoming potential drugs. Glioblastoma multiforme is the most common and most aggressive cancer that begins within the brain.
10 Jun
2016
Eosinophilic pneumonia is a pulmonary disease in which eosinophils accumulate in the lung and leads to disruption of the normal air spaces (alveoli) where oxygen is extracted from the atmosphere. Several different kinds of eosinophilic pneumonia exist and can occur in any age group. There are two types of eosinophilic pneumonia acute eosinophilic pneumonia (AEP) and chronic eosinophilic pneumonia (CEP).
11 Jul
2022
In 2021, the global Usher Syndrome market was valued at USD 147.15 million and is projected to reach at the value of USD 195.37 million by 2028.
26 Jun
2022
Researchers believe CAR macrophages are better at invading and surviving in solid tumours than CAR T cells.
16 Jun
2016
The contraceptives market is anticipated to undergo steady growth sue to increasing public awareness about reproductive health, prime driving factors of the global contraceptives market are technical advancement, preference for avoiding unintentional pregnancy and availability of highly effective female contraceptives.
16 Jun
2016
This report on global breast cancer treatment market studies various drugs used for treatment of breast cancer along with pipeline analysis of upcoming potential drugs. Breast cancer is the second most common cancer observed in women worldwide, accounting for around 17% of all female cancers, making the disease exceptionally prevalent. The predictions shared by GLOBOCON in 2012 suggests that the incidence rate of breast cancer in 2012 was for ages= 65 was 503, 158 and by 2020 it is anticipated that ages=65 will be 643,442.
17 Jun
2016
Microbiome therapeutics market is an emerging market with abundant opportunities in today’s world.
17 Jun
2016
Alopecia, or excessive hair loss (baldness) is common in many men and some women in midlife. This condition may have significant psychological and emotional repercussions. The most effective treatment for alopecia depends on the inherent cause of the condition. The various causes of occurrence of alopecia in men and women are hormonal changes, heredity, stress, pollution, side effects of any medical treatment, dietary habits and chemicals.
20 Jun
2016
Parenteral nutrition or total parenteral nutrition is defined as intravenous infusion of nutrition solutions to patients. Parenteral nutrition is administered in cases where the GI tract is leaking or not functioning, is inaccessible or adequate nourishment from by enteral or oral means is not accomplished. The commercially available premixed solutions adequately provide nutrition for short periods, however for complex patients, it is ideal to adopt a flexible system for personalizing parenteral nutrition.
07 Jul
2016
The National Institute of Diabetes and Digestive and Kidney Diseases, U.S. defines constipation as "condition in which you have fewer than three bowel movements a week, or hard, dry and small bowel movements that are painful or difficult to pass‟. Constipation is classified into two categories: functional constipation and secondary constipation.
08 Jul
2016
The medical gases industry is currently undergoing shift in standards and delivery due to modernization of institutional healthcare and home healthcare market and the means of supply to these areas. The medical gas sector is anticipated to undergo certain revisions in testing and supply requirements from the developed markets.
13 Jul
2016
Fertility patterns worldwide have changed dramatically and a rise in the infertility rates have been observed since the last two decades. Even though newer assisted techniques such as in-vitro fertilization have been well developed, still fertility drugs are the first choice for treatment of infertility issues. Even in the fertility drugs category, hormonal products are preferred the most. Since the human body is governed by hormones, infertility is considered to be caused due to the abnormal play of the hormones.
21 Jul
2016
This report on hyaluronic acid products market studies various product types and applications. Hyaluronic acid products adds value to cell permeability and cell proliferation and considered as an vital constituent of the extracellular matrix.
26 Jul
2016
Growth in healthcare investments, prevalence of angioedema and growing high-risk geriatric population are the major factors driving the global market growth for angioedema treatment. In the next few years the demand for angioedema treatment is expected to increase significantly in the economies such as China and Japan.
28 Jul
2016
This report titled precision medicine market studies various technology type, application type and geographical scenario. In July 2016, The White House announced that it is giving out USD 55.0 million to a collection of hospitals and companies to uncover links between a person’s genome and disease and built a genetic database of initially at least 1 million Americans.
09 Aug
2016
Ophthalmic Drugs Market Valued At USD 17.2 Bn In 2015, And Is Expected To Reach USD 27.6 Bn By 2022, Expanding At A CAGR Of 7.0% From 2016 To 2022
11 Aug
2016
Conventional wound healing turns out unproductive in healing acute wounds such as deep cuts, burn injuries, and chronic ulcers. Introduction of bioactive wound care products has efficiently provided solution to treat such critical wounds and injuries.
11 Aug
2016
Thyroid Gland Disorders Treatment Market Was Valued At USD 1.9 Bn In 2015, And Is Expected To Reach USD 2.5 Mn By 2023, Expanding At A CAGR Of 3.3% From 2016 To 2023
18 Aug
2016
Angiotensin Converting Enzyme (ACE) Inhibitors Market Was Valued At USD 11,477.1 Mn In 2015, And Is Expected To Reach USD 11,094.6 Mn By 2023, Expanding At A CAGR Of (0.5%) From 2016-2023
29 Aug
2016
According to American Liver Foundation, primary biliary cholangitis formerly known as primary biliary cirrhosis (PBC), is a chronic liver disease that gradually destroys the medium-sized bile ducts within the liver. These bile ducts are damaged by inflammation which causes bile to remain in the liver, where gradual injury damages liver cells and causes liver cirrhosis.
31 Aug
2016
Nonalcoholic steatohepatitis (NASH) is also known as ‘fatty liver’ a disorder that develops in patients who are not alcoholic; mainly causes liver damage that is diagnostically indistinguishable from alcoholic hepatitis.
08 Sep
2016
Intraosseous Devices Market Valued At USD 312.9 Mn In 2015, And Expected To Reach USD 401.7 Mn By 2023, Expanding At A CAGR Of 3.2% From 2016 To 2023
14 Sep
2016
Platelet rich plasma (PRP) is a product that contains large number of platelets in a small plasma volume. PRP works as a fibrin tissue adhesive with tissue sealing and hemostatic characteristics.
19 Sep
2016
Trientine Hydrochloride Market Was Valued At US$ 0.42 Bn In 2015, And Is Expected To Reach US$ 0.75 Bn By 2023, Expanding At A CAGR Of 7.5% From 2016 to 2023.
20 Sep
2016
Chronic Myeloid Leukemia (CML) Treatment Market Was Valued At USD 2,828.9 Mn In 2015, And Is Expected To Reach USD 2,072.0 Mn By 2023, Expanding At A CAGR of (3.7%) From 2016 To 2023.
20 Sep
2016
Following the approval of the first monoclonal antibody in 1986, the approval and sales were flat until the introduction of the first chimeric monoclonal antibodies.
01 Oct
2021
The carcinoembryonic antigen market is expected to cross-market value of USD 2,328.5 million in 2027 from USD 1,753.7 million in 2020. It is expected to grow at a CAGR of over 4.1% during the forecast period.
27 Sep
2016
According to the Cleveland Clinic, Aspergillosis is an infection or allergic reaction caused by various kinds of molds found on plants, soil, building materials or rotting vegetables.
19 Oct
2016
In order to prevent cardiovascular diseases, a proper balanced diet is essential such as oily fish, vegetables, fruits, and substantial and appropriate amount of fiber in the body.
05 Apr
2017
Trigeminal Neuralgia Treatment Market Was Valued At US$ 46.53 Mn In 2016, And Is Expected To Reach US$ 99.17 Mn By 2025, Expanding At A CAGR Of 7.60% From 2017 To 2025
30 Nov
2016
Middle East And Africa Female Hygiene Products Market Was Valued At USD 57.2 Mn In 2015, And Is Expected To Reach USD 89.63 Mn By 2023, Expanding At A CAGR Of 5.8% From 2016 To 2023
30 Nov
2016
Malignant Ascites Treatment Market Was Valued At USD 581.9 Mn In 2015, And Is Expected To Reach USD 778.0 Mn By 2024, Expanding At A CAGR Of 3.2% From 2016 To 2024
21 Sep
2017
Multiple Myeloma Treatment Market Was Valued At USD 8,398.3 Mn In 2016, And Is Expected To Reach USD 21,221.8 Mn By 2025, Expanding At A CAGR Of 11.0% From 2017 To 2025
08 Dec
2016
Nootropics Market Was Valued At USD 1,346.5 Mn In 2015, And Is Expected To Reach USD 6,059.4 Mn By 2024, Expanding At A CAGR Of 17.9% From 2016 To 2024
14 Dec
2016
Inulin Market Was Valued At USD 1,407.0 Mn In 2015, And Is Expected To Reach USD 2,615.0 Mn By 2024, Expanding At A CAGR Of 9.5% From 2016 To 2022
22 Dec
2016
Antioxidant Market Was Valued At USD 2329.7 Mn In 2015, And Is Expected To Reach USD 3.512 Mn By 2023, Expanding At A CAGR Of 5.4% From 2016 To 2023
28 Dec
2016
Global Anti-Hypertensive Drugs Market Was Valued At USD 32,214.3 Mn In 2015, And Is Expected To Reach USD 34,925.7 Mn By 2023, Expanding At A CAGR Of 1.2% From 2016 To 2023.
29 Dec
2016
Cancer Supportive Care Market Was Valued At US$ 22,833.4 Mn In 2015, And Is Expected To Reach US$ 34,214.7 Mn By 2023, Expanding At A CAGR Of 4.4% From 2016 To 2024
13 Oct
2017
Bacterial Conjunctivitis Market Was Valued at US$ 458.4 Mn in 2016, And Is Expected To Reach US$ 436.7 Mn by 2025 Decreasing At A CAGR of - 0.54% from 2017 to 2025
26 Mar
2018
Parkinson’s Disease Therapeutics Market was estimated to be USD XX Bn in 2018 and was expected to be worth USD XX Bn by 2026. Explore the market Here!
13 Jan
2017
Fabry disease is a rare, X-linked inherited, disorder of lipid metabolism resulting from the deficient activity of the enzyme, alpha-galactosidase-A. This enzyme normally responsible for the breakdown of globotriaosylceramide, results in abnormal deposits of a particular fatty substance in walls of the blood vessel throughout the body.
29 Aug
2022
Rheumatoid arthritis is an autoimmune, inflammatory disease that causes chronic pain, swelling and loss in the functioning ability of joints. It occurs when the immune system attacks the synovium – the inner lining of membranes that surrounds the joints. In some patients, the antibodies also damage some body systems including the skin, heart, eyes, lungs and blood vessels. Prevalence of rheumatoid arthritis widely varies in different geographic region, the lowest rates is observed in the Asian countries and higher rates among some American populations.
19 Jan
2017
Small Animals Respiratory Diseases Treatment Market Was Valued At USD 18,350.2 Mn In 2015, And Is Expected To Reach USD 23,064.0 Mn By 2024, Expanding At A CAGR Of 2.5% From 2016 To 2024
19 May
2017
Gastrointestinal Agents Market Was Valued At US$ 17,255.3 Mn In 2016, And Is Expected To Reach US$ 21,177.7 Mn By 2025, Expanding At A CAGR Of 2.6% From 2017 To 2025
24 Feb
2017
Global Pharmacogenomics market was estimated to be USD XX Bn in 2016 and was expected to be worth USD XX Bn by 2024. Explore the market Here!
24 Feb
2017
Nosocomial Infection Treatment Market Was Valued At US$ 28,565 Mn In 2015, And Is Expected To Reach US$ 36,746 Mn By 2024, Expanding At A CAGR Of 2.5% From 2016 To 2024
09 Jul
2022
In 2021, the global Treatment-Resistant Depression (TRD) Treatment market was valued at USD 1318.5 million and is projected to reach at the value of USD 1620.77 million by 2028.
27 Feb
2017
Hospital Infection Prevention And Control Market Was Valued At US$ 142.6 Mn In 2015, And Is Expected To Reach US$ 245.6 Mn By 2024, Expanding At A CAGR Of 6.3% From 2016 To 2024
28 Feb
2017
Peptide Therapeutics Market Was Valued At USD 19,475.8 Mn In 2015, And Is Expected To Reach USD 45,542.8 Mn By 2024, Expanding At A CAGR Of 9.8% From 2016 To 2024
21 Mar
2017
Pre-Menstrual Syndrome Treatment Market Was Valued At US$ 4,163.7 Mn In 2015 & Is Expected To Reach US$ 4,985.7 Mn By 2024 Expanding At A CAGR Of 2.0% From 2016-2024
23 Mar
2017
Pompe disease also known as lysosomal storage disorder, is an inherited, rare disease that is characterized by progressive muscle weakness and respiratory disorder. Pompe disease usually occurs in 1 in 40,000 newborn babies, where the lowest rate is observed in the countries like Australia and New Zealand and higher rate among African American populations.
23 Mar
2017
Gaucher disease, also known as lysosomal storage disorder is an inherited, rare disease that occurs due to less glucocerebrosidase (GCase) an enzyme which breaks down glucocerebroside building up around bone marrow, liver and spleen. Gaucher disease usually occurs in 1 in 40,000 to 60,000 newborn babies, where the lowest rate is observed in the Asia Pacific and higher rates among Eastern European populations.
29 Mar
2017
Asthma Therapeutics Market Was Valued At US$ 19.35 Bn In Terms Of Value In 2015, And Is Expected To Reach US$ 23.4 Bn By 2024, Expanding At A CAGR Of 2.1% From 2016 To 2024.
30 Mar
2017
Antibody Drug Conjugate Market Was Valued At USD 1.3 Bn In 2015, And Is Expected To Reach USD 29.3 Bn By 2022, Expanding At A CAGR Of 41.7% From 2016 To 2024
17 Apr
2017
Prostate Cancer Treatment Market Was Valued At US$5.63 Bn In 2016, And Is Expected To Reach US$ 18.4 Bn By 2025 Expanding At A CAGR Of 12.3 % From 2017 - 2025
28 Jul
2022
In 2021, the Global Neurological Disease Treatment Market was valued at USD XX Million and is projected to reach USD XX million by 2028.
27 Apr
2017
Biosimilars Market Was Valued At US$ 3.52 Bn In 2016, And Is Expected To Reach US$ 25.83 Bn By 2025, Expanding At A CAGR Of 23.1% From 2017 To 2025
02 May
2017
Glaucoma Therapeutics Market Was Valued At US$ 4.42 Bn In 2016, And Is Expected To Reach US$ 5.67 Bn By 2025, Expanding At A CAGR Of 2.8% From 2017 To 2025
02 May
2017
Hepatitis B Vaccines Market Was Valued At US$ 1.39 Bn In 2016, And Is Expected To Reach US$ 1.89 Bn By 2025, Expanding At A CAGR Of 3.5% From 2017 To 2025
08 May
2017
Cryptococcosis Market Was Valued At US$ 4.51 Bn In 2016, And Is Expected To Reach US$ 6.76 Bn By 2025, Expanding At A CAGR Of 4.5% From 2017 To 2025
08 May
2017
Chronic Kidney Disease (CKD) Drugs Market Was Valued At US$ 12.4 Bn In 2016, And Is Expected To Reach US$ 17.4 Bn By 2025, Expanding At A CAGR Of 3.9% From 2017 To 2025
09 May
2017
Infectious Disease Treatment Market Was Valued At US$ 153.55 Bn In 2016, And Is Expected To Reach US$ 238.69 Bn By 2025 Expanding At A CAGR Of 4.88 % From 2017 To 2025.
09 May
2017
The Market Was Valued At USD 5.1 Bn In 2015, And Is Expected To Reach USD 15.1 Bn By 2025, Expanding At A CAGR Of 12.4% From 2017 To 2025
10 May
2017
The purpose of this research study titled ‘Bovine Respiratory Disease Treatment Market - Growth, Future Prospects, and Competitive Analysis, 2017 – 2025’ is to provide investors, developers, company executives and industry participants with in-depth analysis to allow them to take strategic initiatives and decisions related to the prospects in the global bovine respiratory disease treatment market. This report presents and analyzes the major trends prevalent in the global bovine respiratory disease treatment market and the market size and forecast.
25 Jul
2017
Psoriasis Treatment Market Was Valued At US$ 7.9 Bn In 2016, And Is Expected To Reach US$ 12.8 Bn By 2025, Expanding At A CAGR Of 5.4% From 2017 To 2025
15 May
2017
Pharmacy Repackaging Systems Market Was Valued At US$ 1,067.3 Mn In 2016, And Is Expected To Reach US$ 2,038.9 Mn By 2025, Expanding At A CAGR Of 7.5% From 2017 To 2025
19 May
2017
Peripheral Neuropathy Market Was Valued At US$ 1,470.9s Mn In 2016, And Is Expected To Reach US$ 1,998.8 Mn By 2025, Expanding At A CAGR Of 3.2% From 2017 To 2025
01 Jun
2017
Asthma And COPD Market Was Valued At US$ 39,021.2 Mn In 2016, And Is Expected To Reach US$ 56,507.7 Mn By 2025, Expanding At A CAGR Of 4.2% From 2017 To 2025
14 Jun
2017
Substance Abuse Treatment market Was Valued At US$ 13,217.9mn In 2016, And Is Expected To Reach US$27,910.0mn By 2025, Expanding At A CAGR Of 8.6% From 2017 To 2025
29 Jun
2017
Cholera Vaccines Market Was Valued At US$ 51.3 Mn In 2016, And Is Expected To Reach US$ 234.5 Mn By 2025, Expanding At A CAGR Of 15.8% From 2017 To 2025
30 Jun
2017
Animal Healthcare Market Was Valued At US$ 32,054 Mn In 2016, And Is Expected To Reach US$ 53,420 Mn By 2025 Expanding At A CAGR Of 5.6 % From 2017 To 2025
03 Jul
2017
Influenza Therapeutics Market Was Valued At US$ 6001.2 Mn In 2016, And Is Expected To Reach US$ 1204.1 Mn By 2025, Expanding At A CAGR Of 7.8% From 2017 To 2025
04 Jul
2017
The Market Was Valued At US$ 319.6 Mn In 2016, And Is Expected To Reach US$ 673.8 Mn By 2025, Expanding At A CAGR Of 8.5% From 2017 To 2025
06 Jul
2017
Respiratory Tract Infection Treatment Market Was Valued At US$ 34,276.8 Mn In 2016, And Is Expected To Reach US$ 59,957.3 Mn By 2025 Expanding At A CAGR Of 6.2 % From 2017 To 2025
10 Jul
2017
Erythropoietin Drugs Market Was Valued At US$ 9,097.7 Mn In 2016, And Is Expected To Reach US$ 19,653.2 Mn By 2025, Expanding At A CAGR Of 9% From 2017 To 2025
11 Oct
2018
Market Was Valued At US$ 4.6 Mn In 2016, And Is Expected To Reach US$ 23.9 Mn By 2025, Expanding At A CAGR Of 17.2% From 2017 To 2025
18 Jul
2017
Allergy Diagnostics And Treatmentmarket Was Valued At US$26,915.8mn In 2016, And Is Expected To Reach US$45,018 Mn By 2025, Expanding At A CAGR Of 5.6% From 2017 To 2025
17 Apr
2018
Post-Traumatic Stress Disorder Therapeutics Market Is Projected To Reach US$ 10,679.5 Bn By 2026, Expanding At A CAGR Of 4.5% From 2018 To 2026 Increasing Demand From Pharmaceutical Industry Is Driving The Market growth by credenceresearch.com. It includes, What Are The Industry Estimates And Outlooks; Which Of Post-Traumatic Stress Disorder Therapeutics Markets Are Going well and which are not? And Leading Players
20 Jul
2017
Chemotherapy Induced Neutropenia Market Was Valued At US$ 7.71 Bn In 2016, And Is Expected To Reach US$ 12.56 Bn By 2025, Expanding At A CAGR Of 5.6% From 2017 To 2025
21 Jul
2017
The Market Was Valued At US$ 729.0 Mn In 2016, And Is Expected To Reach US$ 20,676.0 Mn By 2025, Expanding At A CAGR Of 46.1% From 2017 To 2025
24 Jul
2017
Short Bowel Syndrome Market Was Valued At US$ 315.1 Mn In 2016, And Is Expected To Reach US$ 2,901.0 Mn By 2025, Expanding At A CAGR Of 27.5% From 2017 To 2025
25 Jul
2017
Tuberculosis Treatment Market Was Valued At US$ 838.4 Mn In 2016, And Is Expected To Reach US$ 1,306.6 Mn By 2025 Expanding At A CAGR Of 4.9 % From 2017 To 2025
30 Jul
2017
Multiple Drug Resistance Bacterial Infection Treatment Market Was Valued At US$ 26,169.09 Mn In 2016, And Is Expected To Reach US$ 44,060.77 Mn By 2025 Expanding At A CAGR Of 6.01 % From 2017 To 2025
01 Aug
2017
Amyotrophic Lateral Sclerosis Treatment Market Was Valued At US$ 51.04 Mn In 2016, And Is Expected To Reach US$ 306.6 Mn By 2025, Expanding At A CAGR Of 21.1% From 2017 To 2025
01 Aug
2017
Peptic Ulcer Drugs Market Was Valued At US$ 4.63 Bn In 2016, And Is Expected To Reach US$ 5.92 Bn By 2025, Expanding At A CAGR Of 2.8% From 2017 To 2025
14 Aug
2017
Osteoporosis Treatment Market Was Valued At US$ 11,734.8 Mn In 2016, And Is Expected To Reach US$ 16,512.7 Mn By 2025, Expanding At A CAGR Of 3.9% From 2017 To 2025
21 Aug
2017
Wound Cleansers Market Was Valued At US$ 1,617.6 Mn In 2016, And Is Expected To Reach US$ 2,585.4 Mn By 2025, Expanding At A CAGR Of 5.2% From 2017 To 2025
21 Aug
2017
Multiple Sclerosis Drugs Market Was Valued At US$ 16.13 Bn In 2016, And Is Expected To Reach US$ 27.38 Bn By 2025, Expanding At A CAGR Of 6.3% From 2017 To 2025
21 Aug
2017
Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Market Is Expected To Grow At A CAGR Of 9.8% From 2017 To 2025
28 Aug
2017
Periodontal Therapeutics Market Was Valued At US$ 259.5 Mn in 2016, And Is Expected To Reach US$ 580.5 Mn by 2025, Expanding At A CAGR of 9.2% From 2017 To 2025
17 Nov
2017
Healthcare Prevention Technologies Products And Services Market Was Valued At US$ 177.2 Bn In 2016, And Is Expected To Reach US$ 487.4 Bn By 2025 Expanding At A CAGR Of 10.99 % From 2017 To 2025
30 Aug
2017
Hemophilia Treatment Market Was Valued At US$ 10,042.7 Mn In 2016, And Is Expected To Reach US$ 15,124.7 Mn by 2025, Expanding At A CAGR of 4.5% From 2017 To 2025
31 Aug
2017
Digestive Enzymes Supplements Market Was Valued At US$ 845.8 Mn in 2016, And Is Expected To Reach US$ 1,579.5 Mn by 2025 Expanding At A CAGR of 6.9% From 2017 To 2025
01 Sep
2017
Medical Foods Market Was Valued At US$ 9,857.2 Mn in 2016, and Is Expected To Reach US$ 20,023.9 Mn by 2025, Expanding At A CAGR of 8.1% From 2017 To 2025
04 Sep
2017
Hepatitis C Treatment Market Was Valued At US$ 25.02 Bn In 2016, And Is Expected To Reach US$ 65.48 Bn By 2025, Expanding At A CAGR Of 11.3% From 2017 To 2025
04 Sep
2017
Atopic Dermatitis (AD) Treatment Market Was Valued At US$ 4.04 Bn In 2016, And Is Expected To Reach US$ 7.66 Bn By 2025, Expanding At A CAGR Of 7.4% From 2017 To 2025
04 Sep
2017
Mouth Ulcers are painful sores that can be developed in mucous membrane of oral cavity or at the underneath of gums and restricts individual’s ability to chew, bite or eat.
04 Sep
2017
Osteoporosis is a common disease characterized by porous bone structure, lower bone mass and reduced bone strength. Osteoporosis is a condition where the regrowth of bone is slower than the breakage of bone. It is estimated that worldwide around 200 million population are affected with osteoporosis and it causes around 9 million fractures annually which is a major public concern as the estimated cost of osteoporosis is about 19 billion in United States only.
12 Sep
2017
Hypercholesterolemia Drugs Market, Expanding At A CAGR Of 5.6% From 2017 To 2025
13 Sep
2017
Hereditary Angioedema Market Was Valued At US$ 1,750.2 Mn In 2016, And Is Expected To Reach US$ 3,689.4 Mn By 2025 Expanding At A CAGR Of 8.19% From 2017 To 2025
14 Sep
2017
Kidney Cancer/ Renal Cell Carcinoma Drugs Market Was Valued At US$ 3,302.3 Mn In 2016, And Is Expected To Reach US$ 6,441.9 Mn By 2025, Expanding At A CAGR Of 8.1% From 2017 To 2025
14 Sep
2017
Cancer Biomarkers Market Was Valued At USD 10,514.0 Mn In 2016, And Is Expected To Reach USD 30,284.5 Mn By 2025, Expanding At A CAGR Of 11.5% From 2017 To 2025
22 Sep
2017
Kaposi Sarcoma Market Was Valued At US$ 108.8 Mn In 2016, And Is Expected To Reach US$ 135.6 Mn By 2025 Expanding At A CAGR Of 2.44% From 2017 To 2025
26 Sep
2017
Radiodermatitis Market Was Valued At US$ 295.5 Mn In 2016, And Is Expected To Reach US$ 430.9 Mn By 2025 Expanding At A CAGR Of 4.18% From 2017 To 2025
26 Sep
2017
Aromatherapy Market Was Valued At US$ 1,413.4 Mn in 2016, And Is Expected To Reach US$ 3,226.2 Mn by 2025, Expanding At A CAGR of 9.54% From 2017 To 2025
14 Nov
2017
Gout Therapeutics Market, Expanding At A CAGR Of 15.6% From 2017 To 2025: Increasing Demand From Pharmaceuticals Industry Is Driving The Market growth by credenceresearch.com. It includes, What Are The Industry Estimates And Outlooks; Which Of Gout Therapeutics Markets Are Going well and which are not? And Leading Players
29 Sep
2017
Human Rabies Treatment Market Was Valued At US$ 2.71 Bn In 2016, And Is Expected To Reach US$ 4.32 Bn By 2025, Expanding At A CAGR Of 5.3% From 2017 To 2025
29 Sep
2017
Acute Myeloid Leukemia (AML) Therapeutics Market Was Valued At US$ 404.3 Mn In 2016, And Is Expected To Reach US$ 1,025.9 Mn By 2025, Expanding At A CAGR Of 10.9% From 2017 To 2025
03 Oct
2017
Nuclear Medicine/ Radiopharmaceuticals Market Was Valued At Us$ 4.82 Bn In 2016, And Is Expected To Reach US$ 7.78 Bn By 2025, Expanding At A CAGR Of 5.5% From 2017 To 2025
11 Oct
2017
Pharmaceutical Hot Melt Extrusion Equipment Market Was Valued at US$ 26.1 Mn in 2016, And Is Expected To Reach US$ 39 Mn by 2025, Expanding At A CAGR of 4.5% From 2017 To 2025
12 Oct
2017
Urinary Tract Infection (UTI) Treatment Market Was Valued At US$ xx Bn in 2016, And Is Expected To Reach US$ xx Bn by 2025, Expanding At A CAGR of 3.2% from 2017 to 2025
13 Oct
2017
Advanced Wound Care Management Market Was Valued At US$ 17,671.5 Mn In 2016, And Is Expected To Reach US$ 24,139.4 Mn By 2025 At A CAGR Of 3.46% From 2017 To 2025
25 Oct
2017
Collagen Peptide And Gelatin Market Was Valued At US$ 3,614.1 Mn In 2016, And Is Expected To Reach US$ 9,860.2 Mn By 2025 Expanding At A CAGR Of 10.90 % From 2017 To 2025
30 Oct
2017
Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Was Valued At US$ 784.74 Mn In 2016, And Is Expected To Reach US$ 1,162.1 Mn By 2025, Expanding At A CAGR Of 4.47% From 2017 To 2025
31 Oct
2017
Cracked Heels Treatment Market Was Valued At US$ 1.69 Bn In 2016, And Is Expected To Reach US$ 2.45 Bn By 2025, Expanding At A CAGR Of 4.1% From 2017 To 2025
03 Nov
2017
Oral Thin Film Drugs Market Is Expected Expand At A CAGR Of 8.9% From 2017 To 2025
06 Nov
2017
Biosimulation Market Was Valued At US$ 1.18 Bn In 2016, And Is Expected To Reach US$ 4.12 Bn By 2025, Expanding At A CAGR Of 14.8 % From 2017 To 2025
14 Nov
2017
High Performance Liquid Chromatography Market Was Valued At US$ 3,198.3 Mn In 2016, And Is Expected To Reach US$ 5,104.7 Mn By 2025 Expanding At A CAGR Of 5.17 % From 2017 To 2025
15 Nov
2017
Nutraceutical Ingredients Market Was Valued At US$ 25.4 Bn In 2016, And Is Expected To Reach US$ 49.6 Bn By 2025, Expanding At A CAGR Of 7.6% From 2017 To 2025
19 Nov
2017
Diabetes Drugs Market Was Valued At US$ 49.26 Bn In 2016: Increasing Demand From Pharmaceuticals Industry Is Driving The Market growth by credenceresearch.com. It includes, What Are The Industry Estimates And Outlooks; Which Of Diabetes Drugs Markets Are Going well and which are not? And Leading Players
22 Nov
2017
Sterile Injectables Market was Evaluated at US$ 324.1 Bn in 2016, Expanding at a CAGR of 7.1%.
24 Nov
2017
Erectile Dysfunction Treatment Drugs Market Was Valued At US$ 6.6 Bn In 2016, And Expecting To Exhibit Slow Growth In Future Years Due To Patent Expiration Of Commercially Available Branded Drugs And Market Entrance Of Generic Versions Of Drugs
29 Nov
2017
Diabetes Foot Ulcers Treatment Market Was Valued At US$ 3.15 Bn In 2016, And Is Expected To Show A Lucrative Growth In The Forecast Period, 2017-2025
29 Nov
2017
Americas And Europe Chagas Disease Drugs Market, Expanding At A CAGR Of 1.5% From 2017 To 2025: Increasing Demand From Pharmaceuticals Industry Is Driving The Market growth by credenceresearch.com. It includes, What Are The Industry Estimates And Outlooks; Which Of Americas And Europe Chagas Disease Drugs Markets Are Going well and which are not? And Leading Players
30 Nov
2017
Opioid Drugs Market was Estimated at US$ 33.68 Bn in 2016 and is Predicted to Grow at CAGR of 4.4%
30 Nov
2022
The global bacterial vaginosis drug market is anticipated to grow at a significant CAGR of 4.5% during the forecast period. The global bacterial vaginosis drug industry was estimated to be worth USD 872.6 million in 2021 and was expected to be worth USD 1136.3 million by 2028.
01 Dec
2017
Pain Therapeutics Market Was Valued At US$ 53.2 Bn In 2016, And Is Expected To Reach US$ 85.4 Bn By 2025, Expanding At A CAGR Of 5.3% From 2017 To 2025
02 Aug
2022
Sepsis And Septic Shock Market, Expanding At A CAGR Of 6.1% From 2017 To 2025: Increasing Demand From pharmaceuticals Industry Is Driving The Market growth by credenceresearch.com.
01 Dec
2017
Malarial parasites are developing resistance to anti-malarial drugs, therefore conventional treatment for malaria has proven to be less efficacious. Malaria vaccines would curb the growth of malarial cases and help save millions. Development of malaria vaccine has been one of the greatest challenges faced by research institutes and manufacturers.
05 Dec
2017
Gas Chromatography In Medical Applications Market Was Valued At US$ 2,486.94 Mn In 2016, And Is Expected To Reach US$ 4,381.11 Mn By 2025 Expanding At A CAGR Of 6.25 % From 2017 To 2025
05 Dec
2017
Thebaine is an opiate alkaloid which is extracted form poppy of Papaver somnifer and Papaver bracteatum. Thebaine is also referred as codeine methyl enol ether and paramorphine, it is available as a minor constituent in the range of 0.2 % and 1.5 % in opium poppy and has structural configuration similar to morphine and codeine. Its physical properties are that it is a crystalline, white substance which is slightly soluble in water.
03 Aug
2022
The global Single Cell Protein Products Market is projected to increase at a significant CAGR of 8.7% in the coming years. In 2021, the global rapeseed oil market was valued at USD 98.3 billion and is projected to reach at Value of USD 162.2 billion by 2028.
12 Dec
2017
Anti-epileptic Drugs Market was Valued at US$ 4.08 Bn in 2016.
12 Dec
2017
Mantle Cell Lymphoma Treatment Market Is Set To Grow At A CAGR Of 4.8 % From 2017 To 2025: Increasing Demand From Pharmaceuticals Industry Is Driving The Market growth by credenceresearch.com.
21 Nov
2022
The global cordyceps militaris market is anticipated to grow at a substantial CAGR of 11.1% in the upcoming years. The global cordyceps militaris industry was estimated to be worth USD 745.2 million in 2021 and was expected to be worth USD 1,401.4 million by 2028.
14 Dec
2017
Pharmaceutical Packaging Market Was Valued At US$ 70.87 Bn In 2016, And Is Expected To Reach US$ 130.73 Bn By 2025, Expanding At A CAGR Of 8.8% From 2017 To 2025
19 Dec
2017
Neuroendocrine Tumor Treatment Market Was Valued At US$ 1,159.5 Mn In 2016, And Is Expected To Reach US$ 1,928.9 Mn By 2025 Expanding At A CAGR Of 5.73 % From 2017 To 2025
26 Dec
2017
Bone Glue Market was valued at US$ 1,050.4 Mn in 2016, and is Expected to Reach US$ 1,863.9 Mn by 2025 Expanding at a CAGR of 6.54 % From 2017 to 2025
08 Jan
2018
Myelodysplastic Syndrome (MDS) Treatment Drugs Market, Expanding At A CAGR Of 9.5% From 2017 To 2025
08 Jan
2018
Tardive Dyskinesia (TD) Treatment Drugs Market, Expanding At A CAGR Of 3.7% From 2018 To 2026
08 Jan
2018
Topical Excipients Market is Expected to Grow at a CAGR of 5.72 % from 2017 to 2025
08 Jan
2018
Heparin Market was Valued at US$ 7,714.0 Mn in 2016, and is Expected to Reach US$ 14,853.1 Mn by 2025 Expanding at a CAGR of 7.21 % from 2017 to 2025
09 Jan
2018
Wilson’s Disease Drugs Market Was Valued At US$ 372.5 Mn In 2016, And Is Expected To Reach US$ 592.8 Mn By 2025 Expanding At A CAGR Of 5.19% From 2017 To 2025
06 Aug
2018
Global CAR-T cell Therapy Market was estimated to be USD 72.0 Mn in 2017 and was expected to be worth USD XX Bn by 202. Explore the market Here!
28 Feb
2018
An extensive portfolio of vaccines and constant rising demand has rendered the vaccine contract manufacturing market to be highly competitive with vast presence of key players across geographies.
06 Mar
2018
Pharmaceutical Excipients Market Was Valued At US$ 6,615.7 Mn In 2017 And Expected To Reach US$ 11,938.1 Mn By 2026 Expanding At A CAGR Of 6.87 % From 2018 To 2026 Increasing Demand From Pharmaceutical Industry Is Driving The Market Growth By credenceresearch.com. It Includes, What Are The Industry Estimates And Outlooks; Which Of Pharmaceutical Excipients Drugs Markets Are Going Well And Which Are Not? And Leading Players
19 Mar
2018
The Arthritis Foundation defines psoriatic arthritis as an autoimmune inflammatory disease which primarily affects the skin.
18 Mar
2018
As per the citing of the National Organization for Rare Diseases (NORD) 2016 report, hepatic encephalopathy is described as brain disorder in patients previously suffering with chronic liver ailments such as liver cirrhosis, hepatitis and acute liver failure.
23 Mar
2018
A variety of life-threatening & chronic disorders such as hematological diseases, immune deficiencies, genetic diseases, neurological disorders among others are treated with plasma proteins. The different clinical responses of plasma proteins are due to its unique biochemical profile, and variances in production & processing technologies.
05 Apr
2018
As per the latest research citing of the European Respiratory Journal 2016 report, the global prevalence rate of cough was 9.6%. The largest prevalence was in the Oceania region with 18.1% followed by Europe, America, Asia and Africa with 12.7%, 11.0%, 4.4% and 2.3% respectively.
05 Apr
2018
A veterinary active pharmaceutical ingredient (API) is any chemical substance in a pharmaceutical drug that produces any desired effect in the animals. Veterinary APIs can be a combination of two or more substances in a drug intended to provide some pharmacological effect.
06 Apr
2018
The incidence of radiation toxicity is on a rise with increase in treatment and diagnosis of various diseases using radiation therapy and nuclear medicine, thus driving the overall market growth. Cancer treatment predominantly utilizes radiation therapy to treat tumours and cancerous cells. Growing prevalence of cancer thus increases the rate of radiation therapy indicating growing risk of radiation toxicity.
20 Dec
2018
Botulinum toxin Market is growing at a CAGR of 7.2 %. Report segmented By Product Type (Botulinum Toxin A (BNT-A), Botulinum Toxin B (BNT-B)), By Application (Cosmetics, Neurological Disorders, Other Therapeutic Areas), By End User (Hospitals, Dermatology & Beauty Clinics, Spas & Cosmetic Centers) and Region
10 Apr
2018
Biologics Market is growing at a CAGR of 9.5 %. Report segmented and By Component (Software Platforms, Support Services), Enterprise (Large Enterprises, Small and Medium-sized Enterprises), Deployment Model, End-User By Product (Recombinant Therapeutic Proteins, Blood & Blood Components, Cellular & Gene Therapy, Vaccines), By Disease (Oncology, Autoimmune Diseases, Diabetes, Infectious Diseases, Others) Region
12 Apr
2018
Anti-inflammatory Therapeutics Market is growing at a CAGR of 8.5%. Report segmented By Drug Type (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Biologics, Immune Selective Anti-Inflammatory Derivatives (ImSAIDs)), By Indication (Rheumatoid Arthritis, Chronic Obstructive Pulmonary Disease (COPD), Multiple Sclerosis, Psoriatic Arthritis, Gout) and Region
22 Apr
2018
Global TNF inhibitor market accounted for US$ 43,394.4 Mn in 2017 and expected to attain US$ 181,139.7 Mn in 2026 growing at a CAGR of 16.5% during the forecast period from 2018 to 2026.
22 Apr
2018
The global hypercalcemia treatment market will reach US$ 23,707.8 Mn by 2026 from US$ 9,544.1 Mn in 2017, growing at a CAGR of 10.7% during the forecast period from 2018 to 2026. Hypercalcemia is a condition characterized by the elevated levels of serum calcium ranging above 2.6 mmol/L.
24 Apr
2018
The American College of Obstetricians and Gynecologists states that around 5%-25% pregnant women experience postpartum depression in America. This growing prevalence primarily contribute to the lucrativeness of this market.
07 May
2018
The global H2-receptor antagonists (H2RA) market is projected to grow at a higher CAGR within the forecast period from 2018 to 2026.
08 May
2018
Heart failure, often called as Congestive Heart Failure (CHF), is a chronic, progressive condition in which the heart is incapable to pump blood. There are two types of heart failure namely, left-sided heart failure and right-sided heart failure.
20 Apr
2021
The Subcutaneous Immunoglobulin (SCIg) market is expected to cross market value of USD 8,435.62 million in 2027 from USD 2,136.71 million in 2020. It is expected to grow at a CAGR of over 20.73% during the forecast period.
20 May
2018
Vasculitis Treatment Market is growing at a CAGR of 5.7%. Report segmented By Drug Class (Biologics, Corticosteroids and Immunosuppressant), By Disease Condition (Large Vessel Vasculitis, Medium Vessel Vasculitis and Small Vessel Vasculitis) and Region
20 May
2018
The global impetigo treatment market expected to reach US$ 856.2 Mn by 2026 from US$ 448.6 Mn in 2017, growing at a CAGR of 7.3% during the forecast period from 2018 to 2026. Impetigo is a skin bacterial infection caused primarily by Staphylococcus aureus or Streptococcus pyogenes.
22 May
2018
As per Cleveland Clinic, primary Raynaud’s phenomenon affects around 5% to 10% of the general population. This phenomenon is predominantly observed among the female population aged 15 to 30 years.
30 May
2018
Stroke is predominantly observed among the geriatric population and is globally considered as a major cause of death. The rise in adoption of unhealthy lifestyle patterns, alcohol and smoking addiction has collectively contributed to the rise in prevalence of stroke.
30 May
2018
Global painful diabetic neuropathy (PDN) drugs market accounted to US$ 4,811.8 Mn in 2017 and expected to attain US$ 8,962.0 by 2026 growing at a CAGR of 6.6% during the forecast period from 2018 to 2026.
31 May
2018
The global poultry health market is expected to reach US$ 11,506.3 Mn by 2026, and exhibit steady compound annual growth rate of 7.1% during the forecast period from 2018 to 2026. Good poultry health management is essential for poultry production since culturing a flock with best genetic potential will not grow efficiently if they are diseased or infected.
05 Jun
2018
Ultrasound contrast agents are used to perform or conduct contrast-enhanced ultrasound (CEUS) procedures. Microbubble contrast agents are small spherical bubbles including three phases such as innermost gas phase, shell material enclosing the gas phase, and outermost gas or liquid phase. These microbubbles have unique ability to respond to ultrasound, hence used for ultrasound imaging and research. These bubbles improve the visualization of blood flow pertaining to the surrounding tissue.
02 Jul
2018
The oncology biosimilars market stood at US$ 1,651.5 Mn in 2017 and projected to exhibit a double-digit compound annual growth rate (CAGR) of 28.3% during the forecast period from 2018 to 2026.
14 Jul
2022
In 2021, the global Antihistamines market was valued at USD 215.9 Million and is projected to reach at value of USD 371.2 million by 2028.
30 Jul
2018
The global blood-brain barrier market projected to reach US$ 5,704.2 Mn by 2026 from US$ 696.4 Mn in 2017, growing at a CAGR of 25.0% during the forecast period from 2018 to 2026. The blood-brain barrier (BBB) prevents free flow of elements from circulatory system to the cerebrospinal fluid (CSF) or brain with specific exchange of elements regulated by blood-brain barrier and blood-CSF barrier.
06 Aug
2018
The growing prevalence of infections such as influenzas, ebola virus and HIV have brought significant changes in the outlook of the general population about infections and their management, and consequently in the consumption of anti-infective agents.
07 Aug
2018
The pigmentation disorders treatment market is set to reach US$ 9,649.9 Mn by 2026 from US$ 5,311.5 Mn in 2017 showcasing a steady growth at a compound annual growth rate (CAGR) of 6.9% during the forecast period from 2018 to 2026.
10 Aug
2018
Insomnia Treatment Drugs Market Was Valued At US$ 2,689.6 Mn In 2017, And Is Expected To Reach US$ 4,332.4 Mn By 2026, Expanding At A CAGR Of 5.5% From 2018 To 2026 Increasing Demand From Pharmaceuticals Industry Is Driving The Market growth by credenceresearch.com. It includes, What Are The Industry Estimates And Outlooks; Which Of Insomnia Treatment Drugs Markets Are Going well and which are not? And Leading Players
19 Aug
2018
The chemotherapy induced nausea and vomiting treatment market is set to reach US$ 3,626.1 Mn by 2026 from US$ 2,057.4 Mn in 2017 showcasing progressive growth at a compound annual growth rate (CAGR) of 6.5% during the forecast period from 2018 to 2026.
22 Aug
2018
The premature ejaculation treatment market is set to reach US$ 3,541.4 Mn by 2026 from US$ 1,666.1 Mn in 2017 showcasing progressive growth at a compound annual growth rate (CAGR) of 8.8% during the forecast period from 2018 to 2026.
28 Aug
2018
The global scoliosis management market is growing significantly, was valued at US$ 1,792.4 Mn in 2017 and expected to attain US$ XX Mn by 2026. Worldwide growing surgical procedures, treatment with support braces and exercises and minimally invasive therapies along with growing prevalence of scoliosis diseases drives the overall market growth during the forecast period.
29 Aug
2018
The global foot and mouth disease (FMD) vaccines market to reach US$ 2,935.1 Mn in 2026 and projected to exhibit a compound annual growth rate (CAGR) of 8.1% during the forecast period from 2018 to 2026. FMD is highly contagious viral disease and sometimes fatal affecting cloven hoofed animals that includes domestic and wild bovids.
02 Sep
2018
The global nanoemulsion market projected to reach US$ 14,760.4 Mn by 2026 from US$ 6,827.5 Mn in 2017, growing at a CAGR of 8.9% during the forecast period from 2018 to 2026. Technically nanoemulsions are thermodynamically stable, isotropic, translucent or transparent, and dispersions of oil & water stabilized with a film linking surfactant molecules with a droplet size of 20 to 500nm.
02 Sep
2018
The global cervical cancer diagnostic test market is growing significantly, was valued at US$ 8,779.2 Mn in 2017 and expected to attain US$ XX Mn by 2026. Worldwide growing prevalence of cervical cancer along with growing female population aged between 25 to 60 years are the major factors driving the overall growth of the global cervical cancer diagnostic test market.
18 Sep
2018
The cell surface markers market is set to reach US$ 33,712.7 Mn by 2026 from US$ 16,586.7 Mn in 2017 showcasing progressive growth at a compound annual growth rate (CAGR) of 8.2% during the forecast period from 2018 to 2026. Technological advancements in the production of monoclonal antibodies and manufacturing of cell specific antibodies for disease diagnosis and prognosis are the major factors to drive the cell surface markers market.
25 Sep
2018
The global pulmonary arterial hypertension (PAH) treatment market accounted for a value of US$ 7,802.9 Mn in 2017 and expected to attain US$ 14,642.1 Mn by 2026. Drivers accountable for the market growth are worldwide growing elderly population along with increasing prevalence of pulmonary arterial hypertension due to rising risk factors such as connective tissue disorders, human immunodeficiency virus (HIV) infection, chronic liver diseases, lung diseases, sedentary lifestyle, and other idiopathic conditions.
26 Sep
2018
The medical marijuana market is set to reach US$ 57,582.5 Mn by 2026 from US$ 13,908.7 Mn in 2017 at a compound annual growth rate (CAGR) of 17.1% during the forecast period from 2018 to 2026. According to the International Association for the Study of Pain (IASP) any pain persisting for more than six months in defined as chronic pain.
26 Sep
2018
The global active pharmaceutical ingredient market is growing significantly, valuing at US$ 152.6 Bn in 2017 and expected to reach US$ 273.7 Bn by 2026.
30 Sep
2018
Immunization of livestock has been carried out worldwide for centuries and is also accepted as a cost effective measure of controlling infections. Until recently, vaccines were either live attenuated or inactivated organisms formulated with oil-based adjuvant; however these methods and formulations were not very effective.
30 Sep
2018
Sinusitis treatment drugs market accounted for a market value of US$ 2,006.9 Mn in 2017 and projected to grow at a CAGR of 3.2% during the forecast period from 2018 to 2026. Sinusitis is an inflammation of the paranasal sinuses caused due to allergy, autoimmune reactions or physical obstructions.
02 Oct
2018
The global cancer diagnostics market to reach US$ 115.3 Bn in 2026 growing at compound annual growth rate (CAGR) of 6.1% during the forecast period from 2018 to 2026. The prime factors driving the global cancer diagnostics market is the rising prevalence of cancer worldwide.
07 Oct
2018
The human microbiome market is set to reach US$ 1,990.5 Mn by 2026 from US$ 840.1 Mn in 2017 at a compound annual growth rate (CAGR) of 10.1% during the forecast period from 2018 to 2026. According to the research findings of World Health Organization (WHO), the burden associated with non-communicable diseases is set increase to 57% by 2020.
15 Oct
2018
The cord blood banking services market is set to reach US$ 8,996.7 Mn by 2026 from US$ 2,924.4 Mn in 2017 highlighting convenient growth at a compounded annual growth rate (CAGR) of 13.4% during the forecast period from 2018 to 2026.
22 Oct
2018
The Contract Development and Manufacturing Organization (CDMO) industry had begun decades ago as a niche business by offering specialty services and manufacturing capacities to pharmaceutical companies.
30 Oct
2018
The travel vaccines market is set to reach US$ 6,886.7 Mn by 2026 from US$ 3,592.1 Mn in 2017 showcasing steady growth at a compounded annual growth rate (CAGR) of 7.5% during the forecast period from 2018 to 2026.
12 Nov
2018
The dilated cardiomyopathy therapeutics market is set to reach US$ xx Mn by 2026 from US$ xx Mn in 2017 featuring magnificent growth at a compounded annual growth rate (CAGR) of 4.7% during the forecast period from 2018 to 2026.
28 Jul
2022
The global market for Naloxone was estimated to be worth USD 3415.2 million in 2021 and is anticipated to grow to USD 5887.09 million by 2028. The leading market participants anticipate that the demand for Naloxone will rise significantly over the next few years, creating revenue opportunities totaling USD 2471.89 million between 2022 and 2028.
06 Aug
2022
Treating hypothyroidism or underactive thyroid disease remains the single largest application of levothyroxine sodium. Treatment goals include correcting catabolic imbalances and reversing clinical progressions. According to the AACE (American Association of Clinical Endocrinologists), nearly 27 million people suffer from various thyroid disorders, most suffering from hypothyroidism—autoimmune thyroiditis and iodine deficiency being the most common causes.
27 Jul
2022
In 2021, the global Medical Courier market was valued at USD 5.2 billion and is projected to reach USD 7.12 billion by 2028.
05 Dec
2018
The global fragment-based drug discovery (FBDD) market held US$ 503.4 Mn in 2017 and expected to grow at compound annual growth rate (CAGR) of 11.8% during the forecast period from 2018 to 2026.
11 Dec
2018
The coenzyme A market will showcase impressive growth at a compounded annual growth rate (CAGR) of 8.1% during the forecast period from 2018 to 2026. Coenzyme A is an important biomolecule which has prominent significance in the enzymatic acyl group transfer reactions pertaining to oxidation and synthesis of fatty acids.
12 Dec
2018
The global immunocytokines market is growing significantly. In recent years monoclonal antibodies are being utilized to treat a wide array of cancer-related diseases. These monoclonal antibodies are mainly mono-specific encompassing similar immune cells which are copies of a single parent cell and are concentrated towards a definite cellular target.
12 Dec
2018
The global pneumococcal vaccines market held US$ 7,108.7 Mn in 2017 and expected to grow at compound annual growth rate (CAGR) of 5.1% during the forecast period from 2018 to 2026. Pneumococcal diseases are one of the leading cause of serious illness globally resulting in high number of hospitalization every year.
23 Dec
2018
The photodynamic therapy market is set to grow at an impressive rate with a compounded annual growth rate (CAGR) of 5.7% during the forecast period from 2018 to 2026. As per the statistics provided by World Health Organization (WHO), currently 2 to 3 million non-melanoma and 132,000 melanoma skin cancer occurs throughout the globe annually.
25 Aug
2022
T-Cell Lymphoma Treatment Market is projected to increase at a significant CAGR of 7.8 % in the coming years. In 2021, the global T-Cell Lymphoma Treatment Market was valued at USD 1,538.1 million and is projected to reach the value of USD 2,413.7 million by 2028.
27 Dec
2018
The bispecific antibodies market is set to grow with a compounded annual growth rate (CAGR) of 5.9% during the forecast period from 2018 to 2026. According to the research findings presented by the World Health Organization (WHO), in 2018 cancer is responsible for the death of approximately 9.6 million people throughout the globe.
09 Jan
2019
The global equine healthcare market held US$ 626.2 Mn in 2017 and expected to grow at compound annual growth rate (CAGR) of 4.0% during the forecast period from 2018 to 2026.
09 Jan
2019
The genital herpes treatment drugs market will be featuring magnificent growth at a compounded annual growth rate (CAGR) of 4.9% during the forecast period from 2018 to 2026.
14 Jan
2019
The cervical cancer treatment market will be highlighting excellent growth at a compounded annual growth rate (CAGR) of 5.2% during the forecast period from 2018 to 2026. Cervical cancer occurs in women in age group ranging from 14 to 49 years.
23 Jan
2019
The veterinary biologics market is set to reach from US$ 17,704.7 Mn in 2017 to US$ 29,706.9 Mn by 2026 at a compound annual growth rate (CAGR) of 6.0% during the forecast period from 2018 to 2026. Veterinary biologics are medicinal products obtained from living organism and biological processes.
06 Mar
2020
CBD Oil Market expected to grow at a CAGR of 32.5%. Report Segmented By Type (Hemp-derived, Marijuana-derived), By Application (Food & Beverage Industry, Medical & Pharmaceutical Industry, Cosmetics Industry, Others), By Distribution Channel (Retail Stores, Pharmacies, Online, Others (Supermarket & Hypermarkets, etc.))
03 Mar
2019
The global anticoagulant reversal drugs market expected to grow at compound annual growth rate (CAGR) of 15.3% during the forecast period from 2018 to 2026. Reversing the effects of anticoagulants including novel oral anticoagulants (NOACs), Vitamin K antagonist and others is a major concern in clinical practice especially during life-threatening bleeding episodes and emergency surgery.
06 Mar
2019
The global anticoagulants market was valued at US$ 33,150.7 Mn in 2017 and expected to grow at compound annual growth rate (CAGR) of 6.6% during the forecast period from 2018 to 2026.
20 Mar
2019
The global pharmacy benefit management market was valued at US$ 405.4 Bn in 2017 and expected to grow at compound annual growth rate (CAGR) of 5.4% during the forecast period from 2018 to 2026.
28 Mar
2019
Growing regulatory pressure and challenge of litigations over adverse or side effects, rapidly changing demographic patterns, drying product pipelines and consistent growth in competition from generic manufacturers are some of the prime challenges faced in the life sciences business.
29 Mar
2019
Outsourcing of development and manufacturing activities is critically growing among several pharmaceutical manufacturers.
29 Mar
2019
Bronchitis treatment market accounted for a market value of US$ 3,345.8 Mn in 2017 and projected to grow at a CAGR of 4.9% during the forecast period from 2018 to 2026.
29 Mar
2019
The Intravitreal injectables market will be showcasing stable growth at a compound annual growth rate (CAGR) of 4.8% during the forecast period from 2018 to 2026.
03 Apr
2019
Cutaneous mastocytosis treatment market accounted for a market value of US$ 186.7 Mn in 2017 and projected to grow at a CAGR of 5.6% during the forecast period from 2018 to 2026. Cutaneous mastocytosis is a rare disease in which uncontrolled production of mast cells leads to skin complications such as lesions, blisters, and rashes with aggravated itching.
05 Apr
2019
The generic oncology drugs market is set to reach from US$ 17,151.0 Mn in 2017 to US$ 29,222.5 Mn by 2026 representing undeviated growth at a compounded annual growth rate (CAGR) of 6.1% during the forecast period from 2018 to 2026.
05 Apr
2019
Allergy immunotherapy market accounted for a market value of US$ 1,499.0 Mn in 2017 and projected to grow at a CAGR of 10.1% during the forecast period from 2018 to 2026.
10 Apr
2019
The joint pain injections market is set to reach from US$ 2,146.0 Mn in 2017 to US$ 4,888.5 Mn by 2026 exhibiting outstanding growth at a compound annual growth rate (CAGR) of 9.7% during the forecast period from 2018 to 2026.
29 Apr
2019
The in-vitro fertilization market is set to reach from US$ 15,604.7 Mn in 2017 to US$ 36,854.0 Mn in 2026 projecting outstanding growth at a compounded annual growth rate of 10.1% during the forecast period from 2018 to 2026.
16 May
2019
The life science instrumentation market is set to reach US$ 100,792.7 Mn by 2027 from US$ 57,185.5 Mn in 2018 showcasing moderate growth at a compounded annual growth rate (CAGR) of 6.5% during the forecast period from 2019 to 2027.
21 May
2019
The vitamin D therapy market is set to reach US$ 4,721.9 Mn by 2027 from US$ 1,919.4 Mn in 2018 showcasing spectacular growth at a compounded annual growth rate (CAGR) of 10.6% during the forecast period from 2019 to 2027.
27 May
2019
The learning disability treatment market is set to reach US$ 30,493.1 Mn by 2027 from US$ 17,418.0 Mn in 2018 highlighting steady growth at a compounded annual growth rate (CAGR) of 6.5% during the forecast period from 2019 to 2027.
31 May
2019
Dravet syndrome treatment accounted for a market value of US$ 209.2 Mn in 2018 and projected to grow at a CAGR of 11.7% during the forecast period from 2019 to 2027.
06 Jun
2019
The global freezing of gait treatment market is growing effectually, expected to grow at a CAGR of 7.2%. Globally, increasing prevalence of Parkinson's disease has significantly increased the revenue of oral dopaminergic medications. FDA approval for new drugs, and promising pipeline products in the equipment and devices segment in the Parkinson's disease industry are driving the overall growth freezing of gait treatment market globally.
06 Jun
2019
Alpha thalassemia treatment market accounted for a market value of US$ 526.1 Mn in 2018 and projected to grow at a CAGR of 7.1% during the forecast period from 2019 to 2027.
10 Jun
2019
The Lambert-Eaton Myasthenic Syndrome (LEMS) market is keen to represent linear growth at a compounded annual growth rate (CAGR) of 6.7% during the forecast period from 2019 to 2027.
11 Jun
2019
The neurotrophic keratitis market is set to highlight rapid growth at a compounded annual growth rate (CAGR) of 5.2% during the forecast period from 2019 to 2027.
19 Jun
2019
The paroxysmal nocturnal hemoglobinuria (PNH) is currently valued at US$ 2,341.4 Mn in 2018 and is set to reach US$ 6,203.0 Mn by 2027 projecting stunning growth at a compounded annual growth rate (CAGR) of 11.7% during the forecast period from 2019 to 2027.
21 Jun
2019
Paget’s disease treatment market is projected to grow at a CAGR of 3.4% during the forecast period from 2019 to 2027. Paget’s disease of bone affects the way that bone is renewed & repaired, during this process an uncontrolled level of bone generation occurs that results into an abnormal bone formation.
27 Jun
2019
The anaplastic lymphoma kinase (ALK) inhibitors market is set to reach from US$ 1,496.4 Mn in 2018 to 8,329.1 Mn by 2027 keen to demonstrate exuberating growth at a compounded annual growth rate (CAGR) of 21.2% during the forecast period from 2019 to 2027. Lung cancer is the second most occurring type of cancer in both men and women population worldwide.
27 Jun
2019
Polymyositis treatment market projected to grow at a CAGR of 5.9% during the forecast period from 2019 to 2027. Polymyositis is rare connective tissue disease that causes muscle inflammation leading to muscle weakness.
09 Jul
2019
The pharmaceutical intermediates market is set to reach from US$ 25,965.0 Mn in 2018 to US$ 36,890.6 Mn by 2027 at a compound annual growth rate (CAGR) of 4.0% during the forecast period from 2019 to 2027.
25 Jul
2019
The global dermal fillers market is growing efficiently, expected to grow at a CAGR of 6.6%. Globally, growing minimally invasive cosmetic procedures has significantly increased the revenue of dermal fillers.
29 Jul
2019
Devic’s syndrome (Neuromyelitis optica) treatment accounted for a market value of US$ 156.8 Mn in 2018 and projected to grow at a CAGR of 12.0% during the forecast period from 2019 to 2027. Devic's disease or neuromyelitis optica is an autoimmune disease in which antibodies and immune system cells mainly damage the optic nerves and the spinal cord, but in a few cases affect the brain.
06 Aug
2019
The solid tumor cancer treatment market is set to reach from US$ 121.3 Bn in 2018 to US$ 424.6 Bn by 2027 at a compound annual growth rate (CAGR) of 15.0% during the forecast period from 2019 to 2027.
13 Aug
2019
Neutropenia treatment accounted for a market value of US$ 11,279.2 Mn in 2018 and projected to grow at a CAGR of 5.0% during the forecast period from 2019 to 2027.
14 Aug
2019
The hypoactive sexual desire disorder treatment market is set to expand at a compounded annual growth rate (CAGR) of 5.2% during the forecast period from 2019 to 2027.
19 Aug
2019
The blood and bone marrow cancer treatment market is set to reach from US$ 38.8 Bn in 2018 to US$ 74.9 Bn by 2027 at a compound annual growth rate (CAGR) of 7.7% during the forecast period from 2019 to 2027.
10 Sep
2019
The global spinal muscular atrophy treatment market is growing proficiently, expected to grow at a CAGR of 14.5%.
30 Aug
2022
The Pouchitis Treatment Market is anticipated to grow at a substantial CAGR of 10.40% in the upcoming years. The Global Pouchitis Treatment industry was estimated to be worth USD 63.5 million in 2021 and was expected to be worth USD 114.9 million by 2028.
08 Sep
2022
The Porokeratosis Market is anticipated to grow at a substantial CAGR of 6.50% in the upcoming years. The Global Porokeratosis industry was estimated to be worth USD 1.6 billion in 2021 and was expected to be worth USD 2.3 billion by 2028.
13 Nov
2019
The global central fill pharmacy automation market is developing competently, expected to grow at a CAGR of 10.1%.
07 Oct
2022
The global resin capsules market is anticipated to grow at a substantial CAGR of 4.10% in the upcoming years. The global resin capsules industry was estimated to be worth USD 1.1 billion in 2021 and was expected to be worth USD 1.39 billion by 2028.
02 Sep
2022
The Microbiome DNA Kit Market is anticipated to grow at a substantial CAGR of 11.70% in the upcoming years. The Global Microbiome DNA Kit industry was estimated to be worth USD xx billion in 2021 and was expected to be worth USD xx billion by 2028.
31 Aug
2022
The Paranasal Sinus Cancer Market is anticipated to grow at a substantial CAGR of 4.90% in the upcoming years. The global paranasal sinus cancer industry was estimated to be worth USD xx billion in 2021 and was expected to be worth USD xx billion by 2028.
02 Jan
2021
The VMS Sublingual Products market was valued at USS 6,790 million in 2019 and expected to grow at a CAGR of 10.37% during the forecast period from 2020 to 2027 to reach around USD 10,844 million in 2027.
06 Jan
2021
The Hypoallergenic Infant Formula for CMPA market was valued at USS 5,096 million in 2020 and expected to grow at a CAGR of 12.7% during the forecast period from 2021 to 2027 to reach around USD 12,541 million in 2027.
01 Apr
2021
The Drugs for Schistosomiasis market is estimated to reach at USD 103.4 million in 2027 from USD 73.4 million in 2020. The market is anticipated to grow at a CAGR of 5.6% during the forecast timeline.
02 Aug
2021
N-Acetylcysteine is a supplement form of amino acid named cysteine. It facilitates the bonding of amino acids glycine and glutamine for the creation of an essential antioxidant glutathione inside the human body. N-Acetylcysteine has applications as medicines and nutritional supplements. The global market is going to reach at USD 2,200 million in 2027 from USD 1,032.6 million in 2020, expanding at a CAGR of 21.3% during the period 2021 to 2027.
10 Apr
2021
The Vegan (Vegetarian) Softgel Capsules market is expected to generate the revenue of around USD 423.4 million in 2027 from USD 218.7 million in 2020.
19 Apr
2021
The Attention-Deficit Hyperactivity Disorder (ADHD) Drugs Market is expected to cross market value of USD 34,781 million in 2027 from USD 19,523 million in 2020. It is expected to grow at a CAGR of over 8.7% during the forecast period.
27 May
2021
The global market is likely to attain a market value of USD 1.19 billion in 2027 from USD 0.60 billion in 2020. The CAGR for this market is likely to reach over 12.1% in during 2021 to 2027.
31 Aug
2021
Global Saliva Glucose Biosensor market is expected to generate cumulative value of USD 1,013.67 million over the span between 2021 to 2027. Compound annual growth rate of the Saliva Glucose Biosensor market will be slight under 9.5% during the forecast period.
28 Jun
2022
The WHIM syndrome (Warts, Hypogammaglobulinemia, Infections, and Myelokathexis) is a rare disease that is named after its major symptoms.
15 Sep
2022
The global Cryogenic Vials and Tubes Market is anticipated to grow at a substantial CAGR of 3.60% in the upcoming years. The global Cryogenic Vials and Tubes industry was estimated to be worth USD 164.2 billion in 2021 and was expected to be worth USD 203.01 billion by 2028.
06 Jun
2022
CAR T-cell therapy is sometimes referred to as a sort of cell-based gene therapy as it includes changing the gene inside T cells that empowers them to attack cancer.
14 Jun
2022
Rheumatoid arthritis is an autoimmune disease in which your immune system assaults the tissue that lines your joints.
14 Jun
2022
Dry eye disease (DED) develops when the eyes produce too few tears or the tears evaporate too quickly. One or both eyes may be affected by the illness.
14 Jun
2022
Cirrhosis is a chronic disorder in which the liver slowly gets scarred and damaged over time. These bad scar tissues then replace existing good liver tissues, affecting the normal functioning of the liver.
15 Jun
2022
Thyroid cancer is one of the rare cancers in which is a tiny gland located near the base of the neck. It is a butterfly-shaped gland that develop in the front side of the neck.
15 Jun
2022
Follicular lymphoma is a type of cancer that starts in your white blood cells and progresses to create new and more serious symptoms, such as cancer spreading to other parts of the body.
28 Jun
2022
Nipah virus (NiV) is a new bat-borne zoonotic virus that produces catastrophic encephalitis epidemics every year or so. As per the research, only 10% of Nipah patients transfer the virus to other individual.
28 Jun
2022
Ataxia is a medical condition that stands for the loss of muscular coordination at the time of a voluntary movement is undertaken.
29 Jun
2022
Celiac disease (CD) is a digestive illness that usually affects the small intestine of human body. It's a complicated immunological-mediated disorder in which the immune system damages the small bowel when persons with the condition eat gluten.
29 Jun
2022
Dengue fever is a virus-borne illness that is basically caused by the mosquitos carrying one of the dengue viruses.
04 Jul
2022
Diabetic neuropathy is one of the complications that are related to diabetes in which the human nerve system gets affected.
07 Jul
2022
In 2021, the global Persistent Corneal Epithelial Defects (PCEDs) market was valued at USD XX million and is projected to reach at the value of USD XX million by 2028.
07 Jul
2022
In 2021, the global Prosthetic Joint Infections market was valued at USD 482.9 million and is projected to reach at the value of USD 1043.33 million by 2028.
05 Aug
2022
In 2021, the global Cocaine Intoxication market was valued at USD XX million and is projected to reach at the value of USD XX million by 2028. The demand for Cocaine Intoxication is projected to increase substantially in the coming years.
02 Sep
2022
The global Necrotizing Fasciitis Treatment Market is anticipated to grow at a substantial CAGR of 4.00% in the upcoming years. The global Necrotizing Fasciitis Treatment industry was estimated to be worth USD 2.2 billion in 2021 and was expected to be worth USD 2.8 billion by 2028.
13 Sep
2022
The global transverse myelitis treatment market is anticipated to grow at a substantial CAGR of 3.10% in the upcoming years. The global transverse myelitis treatment industry was estimated to be worth USD XX billion in 2021 and was expected to be worth USD XX billion by 2028.
15 Sep
2022
The Insect Cell Culture Market is anticipated to grow at a substantial CAGR of 8.10% in the upcoming years. The Global Insect Cell Culture industry was estimated to be worth USD 2318.4 million in 2021 and was expected to be worth USD 3699.49 million by 2028.
20 Sep
2022
The pharmaceutical blister packaging market is anticipated to grow at a substantial CAGR of 6.20% in the upcoming years. The pharmaceutical blister packaging industry was estimated to be worth USD 10.1 billion in 2021 and was expected to be worth USD 14.49 billion by 2028.
23 Sep
2022
The global Nutraceutical Excipients Market is anticipated to grow at a substantial CAGR of 6.90% in the upcoming years.The global Nutraceutical Excipients industry was estimated to be worth USD 2052.5 million in 2021 and was expected to be worth USD 3063.01 million by 2028.
